Hutchin Hill Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-293,300
Closed -$22.8M 574
2017
Q3
$22.8M Buy
293,300
+194,200
+196% +$16.1M 0.86% 14
2017
Q2
$8.79M Sell
99,100
-20,100
-17% -$1.69M 0.29% 77
2017
Q1
$9.6M Buy
119,200
+50,600
+74% +$3.95M 0.26% 86
2016
Q4
$4.89M Buy
+68,600
New +$5.39M 0.17% 146
2016
Q1
Sell
-20,100
Closed -$1.55M 719
2015
Q4
$1.55M Buy
+20,100
New +$1.51M 0.04% 359
2014
Q3
Sell
-27,800
Closed -$1.77M 670
2014
Q2
$1.77M Buy
27,800
+21,400
+334% +$1.3M 0.08% 186
2014
Q1
$394K Sell
6,400
-27,700
-81% -$1.61M 0.02% 497
2013
Q4
$1.96M Buy
34,100
+20,700
+154% +$1.17M 0.13% 147
2013
Q3
$714K Sell
13,400
-2,400
-15% -$129K 0.06% 235
2013
Q2
$813K Buy
+15,800
New +$781K 0.08% 189

Other funds holding MDT

Hutchin Hill Capital's MDT Position: Q4 2017 in Review

Hutchin Hill Capital sold out of Medtronic (MDT) in Q4 2017, closing a stake of 293,300 shares — an estimated $22.8M sold.

Hutchin Hill Capital first reported a position in MDT in Q2 2013 and held it in 10 quarters. The position peaked at $22.8M in Q3 2017. 1,409 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

  • Hutchin Hill Capital reported no remaining Medtronic position as of Q4 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 293,300 Medtronic shares in Q4 2017, an estimated $22.8M.
  • Hutchin Hill Capital first reported a position in Medtronic in Q2 2013 and held it in 10 quarters.
  • Hutchin Hill Capital's Medtronic position peaked at $22.8M in Q3 2017.
  • 1,409 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.